Print this page | Back to Web Page

Press Releases

Showing 1-35 of 242

First 1 2 3 4 5 6 7 Next Last

2012
February
February 1	Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

January
January 30	DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
January 25	Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth Quarter and Full-Year 2011
January 18	Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
January 4	Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings
2011
December
December 22	Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease
December 19	Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory
December 15	Abbott to Present at J.P. Morgan Healthcare Conference
December 12	Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators
December 9	Abbott Declares 352nd Consecutive Quarterly Dividend
December 8	Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

November
November 30	Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels
November 28	Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
November 21	Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease
November 15	Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
November 14	New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold
November 9	Abbott Receives CE Mark for New Hepatitis Test
November 8	Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis
November 7	Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
November 6	Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA
November 4	Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
November 4	Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis
November 3	PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition
November 3	Abbott to Present New Data for Key Vascular Products at TCT 2011
November 2	Experts Report that Abbott’s New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense
November 2	Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting
November 2	Abbott to Present at 2011 Credit Suisse Annual Health Care Conference
November 1	Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

October
October 27	Abbott Launches Glucerna® Hunger Smart™ Nutrition Products for People with Diabetes
October 27	Abbott's Lupron Depot-PED (leuprolide acetate for depot suspension) 1-Month Formulation Now Includes 18-Year Long-Term Data in Label
October 25	Abbott Awards CFCareForward Scholarships to Two Students Living with Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
October 24	Abbott Honored With Asian CSR Award for Leadership in Science Education
October 24	Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
October 22	Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select Phase 2b Trial at ECTRIMS/ACTRIMS
October 19	Abbott Reports Strong Ongoing Third Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2011

First 1 2 3 4 5 6 7 Next Last

Narrow by Year

Narrow to Show

For news and views on the company, follow us on Twitter:

Follow @AbbottNews

For a different perspective on Abbott News. . .

View Abbott Features

Home | Select a Country | Site Map | Contact Us | Privacy Policy | Terms of Use

Copyright © 2006, 2011 Abbott Laboratories. Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.